Erlotinib
RxNorm 603203· ERLOTINIB· ORAL
Zydus Lifesciences Limited
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- death3,655
- diarrhoea1,332
- rash1,310
- off label use899
- malignant neoplasm progression889
- fatigue719
- nausea696
- vomiting577
- disease progression566
- decreased appetite510
- anaemia498
- dyspnoea485
- drug resistance473
- asthenia463
- pneumonia419
- dehydration381
View more: Full FDA label on DailyMed →Label effective 20241128